Ex Parte Tyrrell et al - Page 5

              Appeal 2007-0326                                                                      
              Application 09/746,888                                                                

                    We determine that the Examiner has established a prima facie case of            
              obviousness in view of the reference evidence, which prima facie case has             
              not been adequately rebutted by Appellants’ arguments.2  Therefore, we                
              AFFIRM all grounds of rejection in this appeal essentially for the reasons            
              stated in the Answer, as well as those reasons set forth below.                       
                                             OPINION                                                
                    We determine the following factual findings from the record in this             
              appeal:                                                                               
                    (1) Krzysik discloses an absorbent article comprising a bodyside liner,         
                       an outer cover, an absorbent core located between the bodyside               
                       liner and the outer cover, and the liquid permeable bodyside liner           
                       defines a bodyfacing surface on which a lotion formulation has               
                       been applied, where the lotion formulation comprises an emollient,           
                       a wax, and a viscosity enhancer (Abstract; col. 2, ll. 10-30; col. 3,        
                       ll. 12-23; col. 9, ll. 31-41; and the Answer 3-4);                           
                    (2) Krzysik desires a lotion formulation that has a reduced level of            
                       migration, which leads to improved transfer to the wearer’s skin,            
                       and acts as a lubricant to reduce abrasion to the skin and improve           
                       the skin health (Abstract; col. 1, ll. 48-53; and col. 2, ll. 23-25);        
                    (3) Krzysik teaches the inclusion of “active ingredients” in the lotion         
                       formulation to “treat the skin” or act as a skin protectant (col. 11,        
                       ll. 7-22); Krzysik further teaches that additional ingredients can be        

                                                                                                   
              2 We have also considered the Decision in related Appeal No. 2005-1186                
              (S.N. 09/746,872), as well as the record in related Appeal No. 2007-0042              
              (S.N. 09/746,880), and related U.S. Patent Nos. 6,287,581 B1 and 6,475,197            
              B1 (S.N. 09/382,018; see the Specification 2:13-20).                                  
                                                 5                                                  

Page:  Previous  1  2  3  4  5  6  7  8  9  Next

Last modified: September 9, 2013